Yu J, Feng H, Sang Q, Li F, Chen M, Yu B, et al. VPS35 promotes cell proliferation via EGFR recycling and enhances EGFR inhibitors response in gastric cancer. EBioMedicine. 2023;89:104451 pubmed publisher

Bergado B xe1 ez G, Gonzalez Suarez N, Garc xed a L, P xe9 rez Mart xed nez D, Hern xe1 ndez Fern xe1 ndez D, Fundora Barrios T, et al. Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies. Front Oncol. 2022;12:951267 pubmed publisher

Liu Z, Sang X, Wang M, Liu Y, Liu J, Wang X, et al. Melatonin potentiates the cytotoxic effect of Neratinib in HER2+ breast cancer through promoting endocytosis and lysosomal degradation of HER2. Oncogene. 2021;40:6273-6283 pubmed publisher

Marrocco I, Romaniello D, Vaknin I, Drago García D, Oren R, Uribe M, et al. Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models. EMBO Mol Med. 2021;13:e13144 pubmed publisher

Pham T, Jayasinghe M, Pham T, Yang Y, Wei L, Usman W, et al. Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery. J Extracell Vesicles. 2021;10:e12057 pubmed publisher

Gabaev I, Williamson J, Crozier T, Schulz T, Lehner P. Quantitative Proteomics Analysis of Lytic KSHV Infection in Human Endothelial Cells Reveals Targets of Viral Immune Modulation. Cell Rep. 2020;33:108249 pubmed publisher

Klichinsky M, Ruella M, Shestova O, Lu X, Best A, Zeeman M, et al. Human chimeric antigen receptor macrophages for cancer immunotherapy. Nat Biotechnol. 2020;38:947-953 pubmed publisher

O Geen H, Bates S, Carter S, Nisson K, Halmai J, Fink K, et al. Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner. Epigenetics Chromatin. 2019;12:26 pubmed publisher

Matlung H, Babes L, Zhao X, van Houdt M, Treffers L, van Rees D, et al. Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis. Cell Rep. 2018;23:3946-3959.e6 pubmed publisher

Urbanova L, Hradilova N, Moserová I, Vosahlikova S, Sadilkova L, Hensler M, et al. High hydrostatic pressure affects antigenic pool in tumor cells: Implication for dendritic cell-based cancer immunotherapy. Immunol Lett. 2017;187:27-34 pubmed publisher

Zabransky D, Yankaskas C, Cochran R, Wong H, Croessmann S, Chu D, et al. HER2 missense mutations have distinct effects on oncogenic signaling and migration. Proc Natl Acad Sci U S A. 2015;112:E6205-14 pubmed publisher

Falahi F, Huisman C, Kazemier H, van der Vlies P, Kok K, Hospers G, et al. Towards sustained silencing of HER2/neu in cancer by epigenetic editing. Mol Cancer Res. 2013;11:1029-39 pubmed publisher

Bose R, Kavuri S, Searleman A, Shen W, Shen D, Koboldt D, et al. Activating HER2 mutations in HER2 gene amplification negative breast cancer. Cancer Discov. 2013;3:224-37 pubmed publisher